COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization

JAMA Oncol. 2021 Aug 1;7(8):1113-1114. doi: 10.1001/jamaoncol.2021.1218.

Authors

Eleni Korompoki¹, Maria Gavriatopoulou¹, Dimitrios P Kontoyiannis²

Affiliations

¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 33983372
DOI: 10.1001/jamaoncol.2021.1218

No abstract available

MeSH terms

Antibodies, Neutralizing / immunology
COVID-19 / immunology*
COVID-19 Vaccines / immunology*
Humans
Neoplasms / immunology*
Neoplasms / virology
RNA, Messenger / immunology
SARS-CoV-2 / immunology

Substances

Antibodies, Neutralizing
COVID-19 Vaccines
RNA, Messenger